Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking

Nitazoxanide has been investigated for colorectal cancer and breast cancer. However, its molecular targets and pathways have not yet been explored for hepatocellular carcinoma (HCC) treatment. Utilizing a network pharmacology approach, nitazoxanide’s potential targets and molecular pathways for HCC...

Full description

Bibliographic Details
Main Authors:	Shakeel Ahmad Khan, Terence Kin Wah Lee
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	nitazoxanide network pharmacology molecular docking hepatocellular carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.968148/full

Similar Items

Network pharmacology and molecular docking-based investigations of Kochiae Fructus’s active phytomolecules, molecular targets, and pathways in treating COVID-19
by: Shakeel Ahmad Khan, et al.
Published: (2022-08-01)

Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy
by: Shakeel Ahmad Khan, et al.
Published: (2023-02-01)

Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of <i>Cnidium monnieri</i> in Treating Hepatocellular Carcinoma
by: Shakeel Ahmad Khan, et al.
Published: (2022-05-01)

Active ingredients and molecular targets of Taraxacum mongolicum against hepatocellular carcinoma: network pharmacology, molecular docking, and molecular dynamics simulation analysis
by: Yanfeng Zheng, et al.
Published: (2022-07-01)

Antitumor Activity of Nitazoxanide against Colon Cancers: Molecular Docking and Experimental Studies Based on Wnt/β-Catenin Signaling Inhibition
by: Noha M. Abd El-Fadeal, et al.
Published: (2021-05-01)

Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan
by: Qin Zhang, et al.
Published: (2021-02-01)

Comparison Between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children
by: Asmaa A.E. Ali, et al.
Published: (2014-06-01)

Activity of Nitazoxanide Against Viral Gastroenteritis: A Systematic Review
by: Eugene Tan, et al.
Published: (2017-08-01)

Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanide
by: Harish Kumar, et al.
Published: (2016-01-01)

Plant-Waste-Derived Sorbents for Nitazoxanide Adsorption
by: Artur Sokołowski, et al.
Published: (2023-08-01)

Cryptosporidial diarrhea in an immunocompetent adult: role of nitazoxanide
by: Naba Raj Mainali, et al.
Published: (2013-12-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
by: Parvaiz A Koul, et al.
Published: (2024-01-01)

Efficacy of Nitazoxanide, Nitazoxanide-Garlic Combination and Tinidazole in Treatment of Giardia duodenalis and Blastocystis hominis: Coproscopic Assessment
by: Sarah Mohamed Abdo, et al.
Published: (2023-03-01)

Octaarginine Improves the Efficacy of Nitazoxanide against <i>Cryptosporidium parvum</i>
by: Tran Nguyen-Ho-Bao, et al.
Published: (2022-06-01)

In vitro anthelmintic activity of nitazoxanide in comparison to praziquantel against Eurytrema coelomaticum
by: Rafael Luiz Olivo, et al.
Published: (2022-10-01)

Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
by: Rainbow Wing Hei Leung, et al.
Published: (2022-11-01)

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and CholangiocarcinomaSummary
by: Fan Ying, et al.
Published: (2023-01-01)

NITAZOXANIDE IN TREATMENT OF ROTAVIRUS DIARRHEA IN CHILDREN: A SINGLE CENTER STUDY
by: Aneeqa Adnan, et al.
Published: (2021-08-01)

The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
by: Claudio Fenizia, et al.
Published: (2021-07-01)

Network pharmacology- and molecular docking-based approaches to unveil the pharmacological mechanisms of dihydroartemisinin against esophageal carcinoma
by: Haixia Wang
Published: (2022-11-01)

Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19
by: Yongbiao Huang, et al.
Published: (2022-08-01)

Antiviral activity of nitazoxanide against Morbillivirus infections
by: Debora Stelitano, et al.
Published: (2023-12-01)

Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments
by: Shujie Li, et al.
Published: (2022-01-01)

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
by: Fengfeng Li, et al.
Published: (2022-03-01)

Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
by: Brandon Iturbe Esquivel, et al.
Published: (2022-06-01)

In vivo evaluation the efficiency of nitazoxanide with cationic Gemini surfactant on Cryptosporidiosis
by: Zeinab Ahmed, et al.
Published: (2023-12-01)

Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats
by: María Isabel Ruiz-Olmedo, et al.
Published: (2017-03-01)

Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
by: Miaolun Yang, et al.
Published: (2023-01-01)

Comparison of Therapeutic Effect of Anti-Cryptosporidium Nano-Nitazoxanide (NTZ) with Free form of this Drug in Neonatal Rat
by: F. Sedighi, et al.
Published: (2016-09-01)

Network Pharmacology and Molecular Docking Analysis Reveal Insights into the Molecular Mechanism of Shengma-Gegen Decoction on Monkeypox
by: Liujiang Dai, et al.
Published: (2022-11-01)

Transcriptional Differential Analysis of Nitazoxanide-Mediated Anticanine Parvovirus Effect in F81 Cells
by: Xia Su, et al.
Published: (2024-02-01)

Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect
by: Sidra Bashir, et al.
Published: (2023-11-01)

Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma
by: Jian Wang, et al.
Published: (2024-04-01)

Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
by: Eduarda Ribeiro, et al.
Published: (2023-03-01)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
by: Chang-hong Li, et al.
Published: (2021-12-01)

Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?
by: Jessie Ehrisman, et al.
Published: (2013-09-01)

An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
by: Shan Lu, et al.
Published: (2022-03-01)

Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis
by: Amal FarahatAllam, et al.
Published: (2020-04-01)

Synthesis, in vitro bioassays, and computational study of heteroaryl nitazoxanide analogs
by: Tasmia Ahmed, et al.
Published: (2021-05-01)

Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis
by: Husna Khalid, et al.
Published: (2022-10-01)